1-3 of 3
Eleonora Marzanati
Close
Sort by
Journal Articles

Prognostic Impact of Minimal Residual Disease By ASO-RQ-PCR in Multiple Myeloma: A Pooled Analysis of 2 Phase III Studies in Patients Treated with Lenalidomide after Front-Line Therapy

Stefania Oliva, MD, Manuela Gambella, Alessandra Larocca, Stefano Spada, Eleonora Marzanati, Barbara Mantoan, Sara Grammatico, Concetta Conticello, MD, Barbara Gamberi, Massimo Offidani, Anna Marina Liberati, Chiara Pautasso, Paola Omedé, Antonio Palumbo, MD, Mario Boccadoro
Journal: Blood
Blood (2016) 128 (22): 4409.
https://doi.org/10.1182/blood.V128.22.4409.4409
Published: 2016
Journal Articles

Highly Sensitive Droplet Digital PCR for MYD88 L265P Mutation Detection and Minimal Residual Disease Monitoring in Waldenström Macroglobulinemia

Daniela Drandi, Elisa Genuardi, Paola Ghione, Daniele Grimaldi, Barbara Mantoan, Marina Ruggeri, Daniela Barbero, Luigia Monitillo, Marika Vasta, Eleonora Marzanati, Giulia Verardo, Paola Omedè, Federica Cavallo, Mario Boccadoro, MD, Marco Ladetto, Simone Ferrero
Journal: Blood
Blood (2015) 126 (23): 2645.
https://doi.org/10.1182/blood.V126.23.2645.2645
Published: 2015
Journal Articles

Multicolor Flowcytometry Analysis of Hematopoietic Stem and Progenitor Cells Subsets Among Basal and Mobilized Peripheral CD34+ Cells

Valentina Giai, MD, Elona Saraci, Eleonora Marzanati, Christian Scharenberg, MD, Monica De Stefanis, Paola Omedè, PhD, Eva Hellstrom-Lindberg, MD PhD, Antonio Palumbo, MD, Benedetto Bruno, MD PhD, Mario Boccadoro, MD, Dario Ferrero, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5117.
https://doi.org/10.1182/blood.V124.21.5117.5117
Published: 2014